Bailard, Inc. Eli Lilly & CO Transaction History

Bailard, Inc.

$3.58 Billion
Q1 2024

A detailed history of Bailard, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Bailard, Inc. holds 12,551 shares of LLY stock, worth $11.5 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

12,551

Previous 12,987 3.36%

Holding current value

$11.5 Million

Previous $7.57 Million 28.98%

% of portfolio

0.27%

Previous 0.23%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$592.2 - $792.28 $258,199 - $345,434	-436 Reduced 3.36%	12,551 $9.76 Million
Q4 2023 Feb 02, 2024	BUY	$525.19 - $619.13 $302,509 - $356,618	576 Added 4.64%	12,987 $7.57 Million
Q3 2023 Oct 24, 2023	SELL	$434.7 - $599.3 $752,465 - $1.04 Million	-1,731 Reduced 12.24%	12,411 $6.67 Million
Q2 2023 Jul 20, 2023	BUY	$350.74 - $468.98 $1.33 Million - $1.78 Million	3,801 Added 36.76%	14,142 $6.63 Million
Q1 2023 May 08, 2023	SELL	$310.63 - $364.82 $41,624 - $48,885	-134 Reduced 1.28%	10,341 $3.55 Million

Q4 2022 Feb 02, 2023	SELL	$321.55 - $374.67 $33,762 - $39,340	-105 Reduced 0.99%	10,475 $3.83 Million
Q3 2022 Oct 18, 2022	BUY	$296.48 - $337.87 $185,892 - $211,844	627 Added 6.3%	10,580 $3.42 Million
Q2 2022 Jul 27, 2022	BUY	$278.73 - $327.27 $645,259 - $757,630	2,315 Added 30.31%	9,953 $3.23 Million
Q1 2022 Apr 25, 2022	SELL	$234.69 - $291.66 $221,782 - $275,618	-945 Reduced 11.01%	7,638 $2.19 Million
Q4 2021 Feb 10, 2022	SELL	$224.85 - $279.04 $3,372 - $4,185	-15 Reduced 0.17%	8,583 $2.37 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $89,526 - $110,174	404 Added 4.93%	8,598 $1.99 Million
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $32,679 - $42,270	181 Added 2.26%	8,194 $1.88 Million
Q1 2021 May 13, 2021	BUY	$164.32 - $212.72 $345,564 - $447,350	2,103 Added 35.58%	8,013 $1.5 Million
Q4 2020 Feb 03, 2021	SELL	$130.46 - $172.63 $88,712 - $117,388	-680 Reduced 10.32%	5,910 $998,000
Q3 2020 Nov 10, 2020	BUY	$146.22 - $169.13 $42,111 - $48,709	288 Added 4.57%	6,590 $975,000
Q2 2020 Aug 12, 2020	BUY	$136.42 - $164.18 $457,961 - $551,152	3,357 Added 113.99%	6,302 $1.04 Million
Q1 2020 Apr 16, 2020	SELL	$119.05 - $147.35 $2,381 - $2,947	-20 Reduced 0.67%	2,945 $409,000
Q4 2019 Jan 31, 2020	SELL	$106.92 - $132.43 $4,490 - $5,562	-42 Reduced 1.4%	2,965 $390,000
Q3 2019 Oct 18, 2019	SELL	$106.79 - $116.16 $32,037 - $34,848	-300 Reduced 9.07%	3,007 $336,000
Q2 2019 Jul 26, 2019	BUY	$110.79 - $129.32 $56,281 - $65,694	508 Added 18.15%	3,307 $366,000
Q1 2019 Apr 24, 2019	BUY	$111.31 - $131.02 $14,136 - $16,639	127 Added 4.75%	2,799 $363,000
Q4 2018 Feb 05, 2019	BUY	$105.9 - $118.64 $9,742 - $10,914	92 Added 3.57%	2,672 $309,000
Q3 2018 Nov 13, 2018	BUY	$85.86 - $107.31 $221,518 - $276,859	2,580 New	2,580 $277,000
Q1 2018 May 07, 2018	SELL	$74.21 - $87.6 $202,741 - $239,323	-2,732 Closed	0 $0
Q4 2017 Feb 08, 2018	BUY	$81.94 - $87.89 $25,401 - $27,245	310 Added 12.8%	2,732 $0
Q1 2017 Jan 29, 2018	BUY	N/A	2,422	2,422 $204,000

Others Institutions Holding LLY

# of Institutions

3,727

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $872B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bailard, Inc. with notifications on news.

Account